Continuous positive air pressure treatment reduces serum advanced glycation end products in patients with obstructive sleep apnoea syndrome: a pilot study
Authors:
- Kazuhiko KotaniKazuhiko Kotani
- Satoshi KimuraSKSatoshi Kimura
- Ichiro KomadaIKIchiro Komada
- Naoki SakaneNSNaoki Sakane
- Alejandro GugliucciAlejandro Gugliucci
- 22 March 2011
- journal article
- Published by Springer Nature in Primary Care Respiratory Journal
- Vol. 20 (3) , 336-337
Abstract
Nasal continuous positive air pressure (nCPAP) treatment may favourably affect serum levels of advanced glycation end products (AGEs) in patients with obstructive sleep apnoea syndrome (OSAS). At baseline, OSAS patients had significantly higher levels of AGEs than controls. Six months after nCPAP initiation, AGEs decreased significantly. nCPAP treatment could lower AGEs in patients with OSAS.Keywords
This publication has 8 references indexed in Scilit:
- Obstructive Sleep Apnea (OSA) and Excessive Sleepiness Associated with OSA: Recognition in the Primary Care SettingPostgraduate Medicine, 2009
- Receptor for Advanced Glycation End ProductsAnnals of the New York Academy of Sciences, 2008
- Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: Correlation with low molecular AGE adduct clearanceClinica Chimica Acta, 2007
- Advanced Glycation Endproducts in Nondiabetic Patients With Obstructive Sleep ApneaSLEEP, 2006
- Sleep-disordered Breathing and Cardiovascular DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Enhanced Release of Superoxide from Polymorphonuclear Neutrophils in Obstructive Sleep ApneaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Identifying Sleep Apnea from Self-ReportsSLEEP, 1988
- Accelerated age-related browning of human collagen in diabetes mellitus.Proceedings of the National Academy of Sciences, 1984